# ADITEC FLU STUDY: Understanding the Genetic Basis for Immune Responses

> **NCT01682369** · PHASE2 · COMPLETED · sponsor: **University of Oxford** · enrollment: 90 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** TIV (Aggripal)
- **BIOLOGICAL:** ATIV (Fluad)

## Key facts

- **NCT ID:** NCT01682369
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-02
- **Final completion:** 2015-01
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2017-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01682369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01682369, "ADITEC FLU STUDY: Understanding the Genetic Basis for Immune Responses". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01682369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*